These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6828140)

  • 1. Vasopressin alters female sexual behaviour by acting on the brain independently of alterations in blood pressure.
    Södersten P; Henning M; Melin P; Ludin S
    Nature; 1983 Feb 17-23; 301(5901):608-10. PubMed ID: 6828140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal vasopressin antagonist treatment facilitates adult copulatory behavior in female rats and increases hypothalamic vasopressin content.
    Meyerson BJ; Höglund U; Johansson C; Blomqvist A; Ericson H
    Brain Res; 1988 Nov; 473(2):344-51. PubMed ID: 3233496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasopressin on female sexual behavior in male rats.
    Södersten P; Boer GJ; De Vries GJ; Buijs RM; Melin P
    Neurosci Lett; 1986 Aug; 69(2):188-91. PubMed ID: 3763046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
    Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
    Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses to intrathecal administration of arginine vasopressin in rats.
    Riphagen CL; Pittman QJ
    Regul Pept; 1985 Apr; 10(4):293-8. PubMed ID: 3839086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat.
    Ehlers CL; Reed TK; Wang M; Lebrun CJ; Koob GF
    Psychopharmacology (Berl); 1985; 87(4):430-3. PubMed ID: 3936102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic blood flow autoregulation remains unaltered following surgical and pharmacological blockade of central vasopressin.
    Sandor P; Petty M; de Jong W; Palkovits M; de Wied D
    Brain Res; 1991 Dec; 566(1-2):212-8. PubMed ID: 1814538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intracerebroventricular versus intravenous administration of vasopressin on intracranial pressure in the rat.
    Saladin LK; Bruni JE
    Neurol Res; 1993 Jun; 15(3):198-203. PubMed ID: 8103586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit.
    Martin SM; Malkinson TJ; Veale WL; Pittman QJ
    Brain Res; 1985 Nov; 348(1):137-45. PubMed ID: 2933125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central vasopressin impairs the baroreceptor heart rate reflex in conscious rats.
    Brattström A; de Jong W; De Wied D
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):114-7. PubMed ID: 1688967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin interactions with oxytocin in the control of female sexual behavior.
    Pedersen CA; Boccia ML
    Neuroscience; 2006; 139(3):843-51. PubMed ID: 16488546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid pressure during cerebroventricular infusion of angiotensin and vasopressin.
    Barbella YR; Keil LC; Wurpel JN; Severs WB
    Exp Neurol; 1983 Nov; 82(2):325-34. PubMed ID: 6628620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
    J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A daily rhythm in behavioral vasopressin sensitivity and brain vasopressin concentrations.
    Södersten P; De Vries GJ; Buijs RM; Melin P
    Neurosci Lett; 1985 Jul; 58(1):37-41. PubMed ID: 4047474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic activation following central vasopressin receptor stimulation in conscious rats.
    Unger T; Rohmeiss P; Becker H; Ganten D; Lang RE; Petty M
    J Hypertens Suppl; 1984 Dec; 2(3):S25-7. PubMed ID: 6100738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.